Special 4/2013

  • Genomic Therapies and Diagnostics

    In this issue:

    Genomic Therapies and Diagnostics

    Personalised Medicine and Companion Diagnostics are expected to drive growth in the pharmaceutical and diagnostics industries in the future.
    Biotech companies that have acquired expertise in biobanking, sequencing and -omics technologies, as well as in the development of biomarkers, will bene t from pharma’s hunger for personalised ’niche-busters’.

Volume 2014

Volume 2013

Volume 2012

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/magazine/spezial/2013/4/pos/1.html?cHash=f5f2e5fdbfbf799a701ac9c5e77ce04b&sort=desc

Current issue

All issues

Events

All Events

Product of the week

Products